New eye drop enters final testing phase for common glaucoma
NCT ID NCT07335211
Summary
This study is testing a new eye treatment called HUC3-637 for people with open-angle glaucoma or high eye pressure. It's a Phase 3 trial, meaning it's in the final stage of testing before potential approval. Researchers are comparing HUC3-637 against an existing active treatment to see if it's better at lowering eye pressure, which is the main goal of glaucoma management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.